Deltex Medical is a UK medical technology company that designed, manufactured and pioneered Oesophageal Doppler Monitoring (ODM).
Our CardioQ-ODM provides an innovative solution to fluid management in surgery and intensive care. In March 2011, it was recommended by NICE for use in over 800,000 NHS operations. ODM has been shown in successive studies to reduce post-operative complications and consequently, reduce the average length of hospital stay. ODM is the only haemodynamic monitor to be validated within multiple enhanced recovery protocols.
In the UK, Deltex Medical is successfully implementing an evidence based strategy to make CardioQ-ODM Oesophageal Doppler Monitoring, a standard of care in medium and high risk surgery. Working closely with anaesthetists, surgeons and intensivists, our comprehensive team of sales, technical and clinical specialists deliver unrivalled after sales support.
Deltex Medical is now looking to expand its product portfolio in the UK and are looking to source existing and innovative medical technologies for anaesthetic, surgical or critical care applications.
Why Partner with Deltex Medical?
Comprehensive National Coverage
• Seven sales territories supported by twelve clinical specialists
• Dedicated NHS trained clinical training, education and implementation teams
Proven track record for implementing technology within the NHS
• Specific NICE recommendation for ODM
• ODM identified as one of the six High Impact Innovations to be adopted by the NHS in 2013/14
• Intra-operative fluid management now part of NHS provider contract.
Complete after-sales support teams
• Customer service, quality and regulatory, service and repair, sales, technical, marketing, research and development.
